SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

TRxADE HEALTH, Inc. MEDS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

TRxADE HEALTH, Inc. (MEDS) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $7.59. It has a SharesGrow Score of 51/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Financials: revenue is $432M, +105213.4%/yr average growth. Net income is $41.5B (loss), growing at -152721%/yr. Net profit margin is -9618% (negative). Gross margin is 76.8% (+29.2 pp trend).

Balance sheet: total debt is $24M against $70.1B equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 2.89 (strong liquidity). Debt-to-assets is 0%. Total assets: $84.2B.

Analyst outlook: 2 / 2 analysts rate MEDS as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 25/100 (Fail), Health 67/100 (Partial), Moat 58/100 (Partial), Future 100/100 (Pass), Income 10/100 (Fail).

MEDS SharesGrow Score Overview

53/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 58/100

Financials — average growth

PAST 25/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 58/100

Gross margin is + market cap

FUTURE 100/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MEDS

No analyst coverage available for this stock.

MEDS: +105213.4%/yr revenue is, -152721%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

MEDS: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet MEDS: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 2.89 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

MEDS: Gross margin is 76.8% (+29.2 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 58/100. ≥ 70 = Pass.

View details →

Analyst outlook: 2 / 2 analysts rate MEDS as buy (100%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

MEDS: Net profit margin is -9618%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range3.69-44.56

Volume18.99K

Avg Volume (30D)61.78K

Market Cap$13.28M

Beta (1Y)2.17

Dividend Yield$9.5000

Share Statistics

EPS (TTM)-2.70

Shares Outstanding$153.47M

IPO Date2014-02-06

Employees8

CEOSurendra K. Ajjarapu

Financial Highlights & Ratios

Revenue (TTM)$431.61M

Gross Profit$331.48M

EBITDA$-43.51B

Net Income$-41.51B

Operating Income$-43.51B

Total Cash$6.66B

Total Debt$24.14M

Net Debt$-6.64B

Total Assets$84.18B

Price / Earnings (P/E)-2.8

Price / Sales (P/S)0.03

Analyst Forecast

Rating ConsensusBuy

Analysts Covering2

Buy 100% Hold 0% Sell 0%

Company Info

CountryUS

ExchangeNASDAQ Capital Marke

CurrencyUSD

ISINUS89846A4058

Price Chart

MEDS

TRxADE HEALTH, Inc. ↗ · NASDAQ Capital Marke

Healthcare • Medical - Pharmaceuticals

3.69 52WK RANGE 44.56

People Also View

Leafly Holdings, Inc.

Nova Cannabis Inc.

SunLink Health Systems, Inc.

HealthWarehouse.com, Inc.

Leafly Holdings, Inc.

Allstar Health Brands, Inc.

BIMI International Medical Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message